Akso Health vs Concorde International
AHG and CIGL side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHG and CIGL compare
Concorde International grew revenue faster over the last twelve months (18.9% versus −6.4% for Akso Health).
Concorde International keeps more of each dollar of sales as profit, with a net margin of −122% compared with −135% at Akso Health.
Akso Health scores higher on the StockData Score (7 against 4 for Concorde International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHG | CIGL |
|---|---|---|
| Size and price | ||
| Share price | $1.33 | $0.220 |
| Change, 1 year | −9.5% | −89.8% |
| Change, 5 years | −55.2% | – |
| Beta (5Y) | −2.21 | 2.60 |
| Employees | 12 | 109 |
| StockData Score | ||
| Total score | 7 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 1 | 1 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −6.4% | 18.9% (better) |
| Revenue growth, 5Y average | 51.1% | – |
| EPS growth (TTM) | −93.8% | – |
| Profitability | ||
| Gross margin | −0.08% | 30.8% (better) |
| Operating margin | −150% | – |
| Net margin | −135% | −122% (better) |
| FCF margin | −92.5% | −29.7% (better) |
| Return on equity | −9.8% (better) | −535% |
| Return on invested capital | −16.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.66 (better) |
| Current ratio | 21.77 (better) | 1.28 |
| Piotroski F-score | 5 (better) | 4 |
| Ownership | ||
| Held by institutions | 0.01% | – |
| Held by insiders | 0.00% | 67.7% |
| Short interest, % of float | – | 3.0% |
Go deeper
- AHG stock overview
- AHG income statement
- AHG valuation and score
- CIGL stock overview
- CIGL income statement
- CIGL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.